304
Participants
Start Date
May 28, 2014
Primary Completion Date
August 11, 2016
Study Completion Date
October 31, 2016
Ciprofloxacin dispersion for inhalation
Placebo
Phoenix
Scottsdale
Sacramento
San Diego
Torrance
Danbury
Miami
Orlando
Winter Park
Decatur
Duluth
Port Huron
Omaha
Lebanon
Summit
Albuquerque
New York
Chapel Hill
Columbus
Philadelphia
Rock Hill
Spartanburg
Tyler
Seattle
Milwaukee
Greenslopes
Adelaide
Nedlands
Perth
Vancouver
Toronto
Windsor
Saint-Jérôme
Créteil
Grenoble
Nice
Pessac
Rouen
Toulouse
Kutaisi
Tbilisi
Budapest
Nyíregyháza
Székesfehérvár
Törökbálint
Jerusalem
Petah Tikva
Ramat Gan
Tel Aviv
Avellino
Napoli
Parma
Pisa
San Gerardo
Terni
Trieste
Otahuhu
Hamilton
Tauranga
Jesus Maria
La Victoria
Pueblo Libre
San Juan de Miraflores
Bialystok
Krakow
Ruda Śląska
Warsaw
Arad
Bucharest
Cluj-Napoca
Craiova
Iași
Belgrade
Knez Selo
Kragujevac
Sremska Kamenica
Suwon
Daegu
Seoul
A Coruña
Barcelona
Lleida
Valencia
Stockton-on-Trees
Wigan
Cambridge
Colchester
Cottingham
Lancaster
Leeds
London
Manchester
North Sheilds
Southampton
Telford
Lead Sponsor
Collaborators (1)
Grifols Therapeutics LLC
INDUSTRY
Aradigm Corporation
INDUSTRY